VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
XRAY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
XRAYDENTSPLY SIRONA Inc.
$9.46$1.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksXRAYBalance Sheet

DENTSPLY SIRONA Inc. (XRAY) Balance Sheet

30Y historyFree accessUpdated daily

Leverage has risen sharply as equity eroded from $3.3B to $1.4B, pushing debt-to-equity to 1.71, while total debt stayed near $2.3B and goodwill write-downs of $1.3B have left the remaining $1.1B at 79% of equity, limiting further impairment capacity.

Income StatementBalance SheetCash FlowRatios

XRAY Balance Sheet

Annual statement

XRAY Balance Sheet

DENTSPLY SIRONA Inc. (XRAY) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets1.98B2.02B1.75B1.97B1.89B1.85B1.8B2B1.89B2B1.88B1.2B1.21B1.14B1.11B1.01B1.32B1.22B949.86M982.02M718.19M1.03B1.06B727.45M541M484.24M325.45M314.7M322.5M277M256.7M
Cash & Short-Term Investments195M326M272M334M365M339M438M405M309.6M320.6M383.9M284.6M151.64M74.95M80.13M77.13M540.04M450.38M204.25M316.32M65.14M434.52M506.37M163.75M25.65M33.71M15.43M7.3M8.7M9.8M5.6M
Cash Only195M326M272M334M365M339M438M405M309.6M320.6M383.9M284.6M151.64M74.95M80.13M77.13M540.04M450.35M203.99M169.38M65.06M434.52M506.37M163.75M25.65M33.71M15.43M7.3M8.7M9.8M5.6M
Short-Term Investments0000000000000000037K258K146.94M79K0000000000
Accounts Receivable605M688M606M756M685M803M706M828M701.9M746.2M636M399.9M426.6M472.8M442.41M427.71M344.8M348.68M319.26M307.62M290.79M254.82M238.87M241.38M221.26M191.53M133.64M127.91M134.2M114.4M102M
Days Sales Outstanding64.768.2458.3269.5963.7569.2777.1875.1464.2768.261.9854.5853.2858.4855.1461.5256.6658.9253.1255.8758.6254.2351.4656.0953.3561.9254.8256.1961.6157.9356.7
Inventory707M642M564M624M627M515M476M562M598.9M623.1M517.1M340.4M387.1M438.56M402.94M361.76M308.74M291.64M306.13M258.03M232.44M208.18M213.71M205.59M214.49M197.45M133.3M135.5M139.2M124.7M125.4M
Days Inventory Outstanding137.88127.35112.19121.21127.599.77103.23110.4113.94126.01108.2107.38106.81116.56107.19104.44103.3101.51107.2597.1996.2589.892.0294.07100.26128.83126.43137.65148.91142.41150.66
Other Current Assets471M367M153M146M88M84M67M84M172.8M120.7M122.9M132.9M150.08M121.36M130.73M113.41M0-37K000-3.04M028.26M061.55M43.07M44M40.4M28.1M23.7M
Total Non-Current Assets3.21B3.41B4.01B5.4B5.75B7.39B7.55B6.6B6.8B8.38B9.77B3.21B3.44B3.93B3.86B3.74B1.94B1.87B1.88B1.69B1.46B1.38B1.74B1.72B1.55B1.31B541.16M544.9M572.8M497.4M411M
Property, Plant & Equipment971M1B902M978M961M971M967M961M870.6M876M799.8M558.8M588.85M637.17M614.71M591.45M423.11M439.62M432.28M371.41M329.62M316.22M407.53M376.21M313.18M240.89M181.34M180.5M159M147.1M141.5M
Fixed Asset Turnover3.63x3.68x4.21x4.05x4.08x4.36x3.45x4.19x4.58x4.56x4.68x4.79x4.96x4.63x4.76x4.29x5.25x4.91x5.07x5.41x5.49x5.42x4.16x4.18x4.83x4.69x4.91x4.60x5.00x4.90x4.64x
Goodwill1.14B1.15B1.6B2.44B2.69B3.98B3.99B3.4B3.43B4.52B5.95B1.99B2.09B2.28B2.21B2.19B1.3B1.31B1.28B1.13B995.38M0000763.27M00000
Intangible Assets815M974M1.21B1.71B1.9B2.32B2.5B2.18B2.42B2.83B2.96B600.7M670.84M795.32M830.64M791.1M78.74M89.09M103.72M76.17M67.65M1B1.25B1.21B1.13B248.89M344.75M349.4M346.1M103.5M256.2M
Long-Term Investments5M023M00000-552.8M-718M-848.6M-160.3M-165.55M-238.39M-232.64M-249.82M-72.49M-72.52M-69.05M-60.55M-53.19M0000000000
Other Non-Current Assets290M284M278M48M198M121M95M69M76.8M156.2M64.1M59.1M94.27M220.15M204.9M169.89M138M28.84M67.52M118.55M70.51M59.24M79.86M132.19M98.35M60.86M15.07M15M67.7M246.8M13.3M
Total Assets5.19B5.43B5.75B7.37B7.64B9.24B9.35B8.6B8.69B10.38B11.66B4.4B4.65B5.08B4.97B4.76B3.26B3.09B2.83B2.68B2.18B2.41B2.8B2.45B2.09B1.8B866.62M859.6M895.3M774.4M667.7M
Asset Turnover0.68x0.68x0.66x0.54x0.51x0.46x0.36x0.47x0.46x0.38x0.32x0.61x0.63x0.58x0.59x0.53x0.68x0.70x0.78x0.75x0.83x0.71x0.61x0.64x0.73x0.63x1.03x0.97x0.89x0.93x0.98x
Asset Growth %-41.65%-5.63%-21.94%-3.57%-17.27%-1.19%8.68%-0.97%-16.31%-10.95%164.74%-5.32%-8.42%2.13%4.56%45.96%5.51%9.1%5.79%22.66%-9.39%-13.97%14.42%17.18%16.07%107.49%0.82%-3.99%15.61%15.98%11.71%
Total Current Liabilities1.22B1.34B1.59B1.43B1.17B1.26B1.37B995M1.01B946.6M771M476M653.59M796.4M927.78M724.07M360.09M444.56M359.96M312.41M311.43M741.23M404.61M337.68M365.75M358.52M168.14M176.2M194.4M169.3M143.2M
Accounts Payable238M300M241M305M279M262M302M308M283.9M284.4M223M133.6M132.6M132.79M165.29M149.12M114.48M100.85M104.33M82.32M79.95M82.32M91.58M86.34M66.63M69.9M45.76M44.61M42.7M38.9M33.7M
Days Payables Outstanding54.5259.5147.9459.2556.7350.7665.560.5154.0157.5146.6642.1436.5935.2943.9743.0538.335.136.5531.0133.1135.5139.4339.531.1445.6143.445.3245.6844.4340.49
Short-Term Debt215M360M549M322M118M182M299M2M92.4M30.1M21.1M12.1M112.83M309.86M298.96M276.7M7.75M82.17M25.8M1.24M3M412.21M72.88M21.97M4.55M7.63M794K20.2M16.3M24M26.7M
Deferred Revenue (Current)143M74M95M91M84M68M53M29M29.3M8.9M14.1M2.2M3.48M4.92M5.51M00-110.5M0189.41M181.2M159.85M179.76M172.68M190.78M194.36M00000
Other Current Liabilities58M408M64M169M182M212M166M128M339.1M353.3M260.1M166.9M8.28M197.58M287.6M163.48M146.32M0108.29M0114.86M105.55M122.03M56.69M103.79M86.62M121.58M111.39M135.4M106.4M82.8M
Current Ratio1.63x1.51x1.10x1.38x1.62x1.47x1.31x2.01x1.86x2.12x2.44x2.51x1.85x1.44x1.20x1.40x3.65x2.74x2.64x3.14x2.31x1.39x2.61x2.15x1.48x1.35x1.94x1.79x1.66x1.64x1.79x
Quick Ratio1.04x1.03x0.74x0.95x1.08x1.06x0.96x1.45x1.27x1.46x1.77x1.80x1.25x0.89x0.76x0.90x2.79x2.08x1.79x2.32x1.56x1.11x2.08x1.55x0.89x0.80x1.14x1.02x0.94x0.90x0.92x
Cash Conversion Cycle148.06136.08122.56131.56134.51118.29114.91125.04124.2136.7123.52119.81123.5139.75118.36122.91121.66125.33123.82122.05121.77108.52104.05110.65122.47145.14137.85148.52164.84155.92166.87
Total Non-Current Liabilities2.62B2.75B2.22B2.65B2.66B2.98B3.04B2.51B2.54B2.79B2.76B1.59B1.67B1.7B1.8B2.15B987.95M736.42M882.72M846.76M595.86M424.33M948.97M985.42M884.1M829.68M173.55M212M284.4M177.2M154.6M
Long-Term Debt1.99B2.02B1.59B1.8B1.83B1.91B1.98B1.43B1.56B1.61B1.51B1.14B1.15B1.17B1.22B1.49B604.01M387.15M423.68M482.06M367.16M270.1M779.94M790.2M769.82M723.52M109.5M145.3M217.5M105.5M75.1M
Capital Lease Obligations363M93M91M125M149M149M130M120M00000000000000000000000
Deferred Tax Liabilities323M86M129M228M287M391M381M480M552.8M718M848.6M160.3M165.55M238.39M232.64M249.82M72.49M72.52M69.05M60.55M53.19M42.91M58.2M51.24M27.04M32.53M16.82M20.2M18.8M27.6M30M
Other Non-Current Liabilities443M457M415M502M399M528M554M480M975.8M1.18B1.25B446.5M521.59M537.49M573.04M657.16M383.93M349.27M389.99M364.69M175.51M111.31M110.83M143.97M87.24M73.63M47.23M46.5M48.1M44.1M49.5M
Total Liabilities3.84B4.09B3.81B4.08B3.83B4.24B4.42B3.51B3.55B3.74B3.53B2.06B2.33B2.5B2.72B2.87B1.35B1.18B1.24B1.16B907.29M1.17B1.35B1.32B1.25B1.19B341.68M388.2M478.8M346.5M297.8M
Total Debt2.29B2.47B2.27B2.3B2.15B2.29B2.46B1.6B1.66B1.61B1.51B1.14B1.15B1.17B1.22B1.49B604.01M387.15M449.47M483.31M370.16M682.32M852.82M812.17M774.37M731.16M110.29M165.5M233.8M129.5M101.8M
Net Debt2.09B2.14B2B1.97B1.78B1.96B2.02B1.19B1.35B1.29B1.13B856.4M1B1.09B1.14B1.41B63.98M-63.2M245.48M313.92M305.09M247.79M346.45M648.42M748.72M697.45M94.86M158.2M225.1M119.7M96.2M
Debt / Equity1.69x1.84x1.17x0.70x0.56x0.46x0.50x0.31x0.32x0.24x0.19x0.49x0.50x0.45x0.54x0.79x0.32x0.20x0.28x0.32x0.29x0.55x0.59x0.72x0.92x1.20x0.21x0.35x0.56x0.30x0.28x
Debt / EBITDA3.03x4.09x-8.91x-2.40x7.42x2.37x--2.08x2.29x2.01x2.13x2.39x3.86x1.35x0.87x1.03x1.19x1.02x5.53x2.48x2.59x2.58x3.14x0.54x0.87x1.31x0.79x0.69x
Net Debt / EBITDA2.77x3.55x-7.62x-2.05x6.09x1.77x--1.55x1.72x1.74x1.99x2.23x3.66x0.14x-0.14x0.56x0.77x0.84x2.01x1.01x2.07x2.49x3.00x0.46x0.84x1.26x0.73x0.65x
Interest Coverage0.02x-4.52x-12.57x-1.16x-15.23x9.93x-0.06x12.41x-24.69x-40.93x13.28x6.90x9.51x8.40x6.82x6.72x14.89x21.61x11.93x31.88x30.19x17.20x12.04x10.42x6.65x-16.14x17.60x0.90x16.36x19.92x
Total Equity1.35B1.34B1.94B3.29B3.81B5B4.93B5.09B5.13B6.64B8.13B2.34B2.32B2.58B2.25B1.88B1.91B1.91B1.59B1.52B1.27B1.24B1.44B1.12B837.19M609.96M524.93M471.4M416.5M427.9M369.9M
Equity Growth %-104.91%-31.03%-41.01%-13.59%-23.71%1.26%-3.14%-0.74%-22.71%-18.27%247.35%0.74%-9.92%14.61%19.39%-1.35%0.15%20.11%4.7%19.02%2.6%-14.04%28.69%34.08%37.25%16.2%11.36%13.18%-2.66%15.68%15.85%
Book Value per Share6.806.729.5615.5417.6922.6922.5122.7022.8828.9536.6716.4216.1017.7815.6313.1313.0812.7010.479.808.057.668.816.965.233.863.342.972.592.632.29
Total Shareholders' Equity1.35B1.34B1.94B3.29B3.81B5B4.93B5.09B5.12B6.63B8.11B2.34B2.32B2.54B2.21B1.85B1.84B1.83B1.59B1.52B1.27B1.24B1.44B1.12B835.93M609.52M520.37M468.9M413.8M423.9M365.6M
Common Stock3M3M3M3M3M3M3M3M2.6M2.6M2.6M1.6M1.63M1.63M1.63M1.63M1.63M1.63M1.63M1.63M814K814K814K814K814K814K543K500K000
Retained Earnings-1.54B-1.56B-835M205M456M1.51B1.2B1.4B1.23B2.32B3.95B3.59B3.38B3.1B2.82B2.54B2.32B2.08B1.84B1.58B1.35B1.15B1.13B889.6M730.97M597.41M490.17M402.4M324.7M301.1M237.3M
Treasury Stock-3.08B-3.1B-3.14B-2.92B-2.65B-2.54B-2.41B-2.3B-2.15B-1.96B-1.65B-898.4M-841.6M-748.51M-713.74M-727.98M-711.65M-532.02M-479.63M-387.11M-328.18M-138.15M-36.48M-39.84M-52.48M-60.82M-68M-35.92M000
Accumulated OCI-647M-639M-730M-636M-628M-592M-464M-600M-478.7M-291M-705.7M-594M-441.14M-69.06M-144.2M-190.97M24.16M83.54M39.61M145.82M79.91M56.45M164.1M104.54M-275K-80.81M-54.23M-49.7M-80.2M-65M-56.3M
Minority Interest-1M1M1M1M1M1M3M2M11.9M11.6M11.6M1.4M919K42.92M40.74M36.07M70.53M74.85M0296K222K188K600K418K1.26M437K4.56M2.5M2.7M4M4.3M

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Goodwill impairment and negative retained earnings

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Shrinking Amidst Restructuring

Total assets contracted from $7.1B in 2024Q1 to $5.2B in 2026Q2, a 27% decline, while equity fell from $3.3B to $1.4B, reflecting persistent losses and asset write-downs.

The balance sheet is clearly contracting, with total assets down $1.9B over the period. The decline is driven by a combination of goodwill impairments (goodwill fell from $2.4B to $1.1B) and accumulated losses, as retained earnings turned deeply negative. This suggests the company is in a restructuring phase, shedding assets and absorbing charges, which may indicate a lower future earnings base.

Leverage Rising as Equity Erodes

Debt-to-equity climbed from 0.68 in 2024Q1 to 1.71 in 2026Q2, while total debt remained near $2.3B, indicating leverage is rising due to equity erosion rather than new borrowing.

Total debt has been relatively stable around $2.2-2.5B, but the D/E ratio has more than doubled because equity has been cut in half. This suggests the company is not taking on new debt but is becoming more leveraged as losses reduce the equity base. The debt load appears manageable in absolute terms, but the trend is concerning if losses persist, as it could strain future cash flows and refinancing capacity.

Asset Base Shifting Away from Intangibles

Goodwill fell from $2.4B to $1.1B over ten quarters, while PPE remained stable near $1B, indicating a shift from intangible-heavy to more tangible asset mix, reducing impairment risk.

The significant reduction in goodwill suggests the company has taken large impairment charges, likely related to prior acquisitions. This reduces the risk of future goodwill write-downs but also indicates that the company's growth through acquisitions has not generated the expected returns. The stable PPE suggests ongoing investment in fixed assets, but the overall asset base is shrinking, which may limit future revenue-generating capacity.

Equity Quality Deteriorating with Negative Retained Earnings

Retained earnings swung from $190M positive in 2024Q1 to -$1.5B in 2026Q2, while equity fell to $1.4B, indicating the company has consumed its historical earnings buffer.

The negative retained earnings are a red flag, as they indicate cumulative losses have wiped out all prior profits. This reduces the quality of equity, as the remaining equity is likely supported by other components like paid-in capital. The company continues to pay dividends (~$32M per quarter) despite losses, which may be unsustainable and could further erode equity if losses persist.

Liquidity Improving but Cash Buffer Thin

Current ratio improved from 1.10 in 2025Q1 to 1.63 in 2026Q2, but cash remains low at $239M, providing limited cushion against operational shocks.

The current ratio has improved, suggesting better short-term liquidity management, but the absolute cash balance is modest relative to the company's size and debt load. With total debt of $2.3B, the cash position covers only about 10% of debt, which may indicate reliance on operating cash flow or refinancing. The improvement in current ratio is positive, but the thin cash buffer warrants monitoring.

Goodwill Impairment Risk Largely Realized

Goodwill has already been written down by $1.3B over ten quarters, but the remaining $1.1B still represents 79% of equity, leaving limited room for further impairments.

The company has already taken significant goodwill impairments, which have contributed to the negative retained earnings. However, the remaining goodwill is still substantial relative to equity, meaning any further impairment could severely impact the already strained equity base. Investors should monitor the carrying value of goodwill against the company's market performance, as further write-downs could push equity into negative territory.

XRAY — Frequently Asked Questions

Quick answers to the most common questions about buying XRAY stock.

What are the total assets of DENTSPLY SIRONA Inc. (XRAY)?

As of 2025, DENTSPLY SIRONA Inc. (XRAY) had total assets of $5.43B including $2.02B in current assets.

How much debt does DENTSPLY SIRONA Inc. (XRAY) have?

DENTSPLY SIRONA Inc. (XRAY) carries total debt of $2.47B, offset by $326.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of DENTSPLY SIRONA Inc.?

DENTSPLY SIRONA Inc. (XRAY) has total shareholders' equity (book value) of $1.34B ($6.72 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is DENTSPLY SIRONA Inc.'s current ratio and liquidity?

DENTSPLY SIRONA Inc. (XRAY) reported a current ratio of 1.51x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.